Close X
Tuesday, December 3, 2024
ADVT 
International

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Darpan News Desk IANS, 02 May, 2022 11:25 AM
  • Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

New York, May 2 (IANS) Omicron's latest subvariant BA.2.12.1, responsible for about one-fourth of Covid-19 cases in the US, shows that the virus is not showing any signs of decline even over two years after it was first detected in humans.

BA.2.12.1 has also been detected in Australia and New Zealand.

Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

According to virologists, although the SARS-CoV-2 virus has repeatedly changed its structure and chemistry, it still has abundant evolutionary space to explore, Washington Post reported.

While existing vaccination can still reduce the risk of severe Covid disease, the variants can evade many of the neutralising antibodies that are the immune system's front line of defence.

"It's evolving at a fairly rapid rate. I do think we need to aggressively consider whether we should update vaccines, and do it soon," Jesse Bloom, a computational biologist at the Fred Hutchinson Cancer Research Center in Seattle was quoted as saying.

"The evolution is much more rapid and expansive than we initially estimated," added Michael Osterholm, infectious-disease expert at the University of Minnesota.

"Every day I wake up, I fear there will be a new subvariant that we will have to consider. . . We're seeing sub-variants of sub-variants," he added.

Other mutations include BA.4 and BA.5, recently identified by scientists in South Africa. It has led to a fresh wave of Covid in the country.

Besides South Africa, the sub variants have also been detected in more than 20 countries including Australia, Austria, Belgium, China, Israel, Denmark, France, Germany, Pakistan, UK, US and Switzerland.

Apart from mutation, the virus has another trick up its sleeve: recombination. It happens when two distinct strains infect a single host simultaneously and their genes become entangled, the Post reported.

The recombination process is the origin of what's known as Omicron XE. That recombinant probably emerged from a person co-infected with the original Omicron variant and the BA.2 subvariant.

It was always possible in theory, but the identification of actual recombinants provides "proof of concept," Jeremy Luban, a virologist at the University of Massachusetts Medical School was quoted as saying.

The worst-case scenario would be the emergence of a variant or recombinant that renders current vaccines largely ineffective at blocking severe disease. But so far, that hasn't happened. And no "recombinant" has spread like Omicron or other recent variants and sub-variants, the report said.

MORE International ARTICLES

20 killed as Israel strikes Gaza after Hamas rocket barrage

20 killed as Israel strikes Gaza after Hamas rocket barrage
Tensions simmering in Jerusalem in recent days have taken deadly turn as militants in the Gaza Strip and Israel exchanged attacks, with at least 20 people killed, according to officials.

20 killed as Israel strikes Gaza after Hamas rocket barrage

As virus engulfs India, diaspora watches with despair

As virus engulfs India, diaspora watches with despair
Many Indian Americans are wracked with guilt over emerging from more than a year of isolation as relatives overseas struggle to find vaccines, hospital beds and, fatefully, their breath.

As virus engulfs India, diaspora watches with despair

US officials: Anxiety drove vaccine reactions in 5 states

US officials: Anxiety drove vaccine reactions in 5 states
Many of the 64 people affected either fainted or reported dizziness. Some got nauseous or vomited, and a few had racing hearts, chest pain or other symptoms. 

US officials: Anxiety drove vaccine reactions in 5 states

Pfizer, BioNTech seek EU's OK to use COVID vaccine on kids

Pfizer, BioNTech seek EU's OK to use COVID vaccine on kids
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.

Pfizer, BioNTech seek EU's OK to use COVID vaccine on kids

Buy American 'does not violate' trade deals: Biden

Buy American 'does not violate' trade deals: Biden
In the same breath, however, the speech marking Biden's first 100 days as commander-in-chief offered a measure of comfort by suggesting Buy American would not offend the terms of trade deals like the U.S.-Mexico-Canada Agreement.

Buy American 'does not violate' trade deals: Biden

White House plans to share vaccines based on need

White House plans to share vaccines based on need
Psaki says the U.S. is waiting for approval from the Food and Drug Administration to share 10 million doses "in the coming weeks."

White House plans to share vaccines based on need